IXICO plc

LSE:IXI.L

Sector

🏥 Health Care

Industries

🔬 Clinical Trials

🤖 Artificial Intelligence (AI)

📊 Big Data

💻 Telehealth

Location

United Kingdom

Market Cap

USD 13.85 M

Share Price

USD 0.14

Avg Daily Volume

57,055

Change (1 day)

-1.04%

Change (1 year)

54.48%

Change (YTD)

-5.30%

IXICO plc Net Cash Used For Investing Activities for the year ending September 30, 2024: USD -504.19 K

IXICO plc Net Cash Used For Investing Activities is USD -504.19 K for the year ending September 30, 2024, a -77.83% change year over year. Net cash used for investing activities is total cash inflows and outflows related to activities intended to generate future income and cash flows from investments.

IXICO plc Net Cash Used For Investing Activities for the year ending September 30, 2023 was USD -2.27 M, a -9.18% change year over year.
IXICO plc Net Cash Used For Investing Activities for the year ending September 30, 2022 was USD -2.50 M, a -13.69% change year over year.
IXICO plc Net Cash Used For Investing Activities for the year ending September 30, 2021 was USD -2.90 M, a 96.78% change year over year.
IXICO plc Net Cash Used For Investing Activities for the year ending September 30, 2020 was USD -1.47 M, a 133.94% change year over year.

Quarterly
Annual
TTM

From:

To:

Zoom:

Key data

Date	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities	Depreciation And Amortization	Dividends Paid

LSE: IXI.L

IXICO plc

CEO	Mr. Bram Goorden M.Sc.
IPO Date	April 25, 1996
Location	United Kingdom
Headquarters	Griffin Court
Employees	81
Sector	🏥 Health Care
Industries Clinical Trials 🤖 Artificial Intelligence (AI) 📊 Big Data 💻 Telehealth

Description

IXICO plc provides data analytics services to the biopharmaceutical industry in the United Kingdom, Switzerland, Netherlands, Ireland, rest of Europe, the United States, and internationally. Its services include collection, analysis, management, and reporting on data generated in the course of a clinical study. The company's technologies comprise Assessa, a secure online digital platform that provides clinical decision support for patient selection and post-marketing surveillance; and TrialTracker, a platform that delivers imaging services designed to manage the complex imaging workflow from image upload, quality control, and reading/analysis to reporting and data transfer. Its focused therapeutic areas include Alzheimer's, Parkinson's, Huntington's, Multiple Sclerosis and other demyelinating diseases, Progressive Supranuclear Palsy, and other rare neurological diseases. The company also engages in the data collection, optimization, and analytics of rare neurological disorders; offers drug development analytics, imaging operation services, and post marketing surveillance services, as well as consultancy services; and provides end-to-end services, such as trail design and consultation, project management, imaging site set-up and management, data management, reading and analysis, and regulatory pathway. IXICO plc was incorporated in 1995 and is based in London, the United Kingdom.

Similar companies

NTRA

Natera, Inc.

USD 167.96

-0.12%

VCYT

Veracyte, Inc.

USD 27.38

2.13%

BSX

Boston Scientific Corporation

USD 106.53

1.86%

REL.L

RELX Plc

USD 54.03

1.59%

SHL.DE

Siemens Healthineers AG

USD 54.95

0.27%

COR

Cencora, Inc.

USD 299.42

0.96%

Edwards Lifesciences Corporation

USD 78.21

1.37%

GEHC

GE HealthCare Technologies Inc.

USD 74.38

-0.64%

DXCM

DexCom, Inc.

USD 86.33

1.52%

IQV

IQVIA Holdings Inc.

USD 157.47

-0.44%

Laboratory Corporation of America Holdings

USD 260.59

1.41%

BAX

Baxter International Inc.

USD 30.39

-0.36%

ILMN

Illumina, Inc.

USD 94.79

0.67%

HOLX

Hologic, Inc.

USD 65.01

-0.15%

SGI

Somnigroup International Inc

USD 67.51

1.29%

TORNTPHARM.NS

Torrent Pharmaceuticals Limited

USD 39.09

3.96%

FPH.NZ

Fisher & Paykel Healthcare Corporation Limited

USD 22.13

0.45%

ICLR

ICON Public Limited Company

USD 144.56

-1.49%

ZYDUSLIFE.NS

Zydus Lifesciences Limited

USD 11.49

0.24%

RGC

Regencell Bioscience Holdings Limited

USD 17.40

-13.82%

ASND

Ascendis Pharma A/S

USD 172.22

-0.42%

PEN

Penumbra, Inc.

USD 256.43

1.12%

EXAS

Exact Sciences Corporation

USD 53.65

3.55%

ABBOTINDIA.NS

Abbott India Limited

USD 408.73

5.97%

CTEC.L

ConvaTec Group Plc

USD 3.97

0.08%

002252.SZ

Shanghai RAAS Blood Products Co., Ltd.

USD 0.96

-0.65%

Guardant Health, Inc.

USD 50.86

1.66%

300832.SZ

Shenzhen New Industries Biomedical Engineering Co., Ltd.

USD 7.80

-2.41%

DIA.MI

DiaSorin S.p.A.

USD 107.84

-1.95%

688617.SS

APT Medical Inc.

USD 41.29

1.54%

AFX.DE

Carl Zeiss Meditec AG

USD 66.78

1.21%

3347.HK

Hangzhou Tigermed Consulting Co., Ltd.

USD 4.54

-0.29%

LNTH

Lantheus Holdings, Inc.

USD 81.49

0.93%

TFX

Teleflex Incorporated

USD 119.47

-0.09%

OPCH

Option Care Health, Inc.

USD 32.25

0.78%

IRTC

iRhythm Technologies, Inc.

USD 154.71

1.32%

600079.SS

Humanwell Healthcare (Group) Co.,Ltd.

USD 2.88

-0.31%

TMDX

TransMedics Group, Inc.

USD 131.45

1.07%

ADMA

ADMA Biologics, Inc.

USD 18.16

-1.30%

RDNT

RadNet, Inc.

USD 57.12

-1.60%

LAURUSLABS.NS

Laurus Labs Limited

USD 8.21

3.42%

002065.SZ

DHC Software Co.,Ltd.

USD 1.36

4.21%

IPCALAB.NS

Ipca Laboratories Limited

USD 15.58

-0.70%

INSP

Inspire Medical Systems, Inc.

USD 132.41

2.08%

600566.SS

Hubei Jumpcan Pharmaceutical Co., Ltd.

USD 4.04

2.01%

GLAND.NS

Gland Pharma Limited

USD 20.84

-0.35%

MOVE.SW

Medacta Group SA

USD 166.12

-0.02%

002603.SZ

Shijiazhuang Yiling Pharmaceutical Co., Ltd.

USD 1.95

-0.21%

JBCHEPHARM.NS

J. B. Chemicals & Pharmaceuticals Limited

USD 21.07

3.07%

PRCT

PROCEPT BioRobotics Corporation

USD 56.91

-2.93%

StockViz Staff

June 29, 2025

Any question? Send us an email